Image Image Image Image Image Image Image Image Image Image
Accessibilitat
Aneu a dalt

Amunt

Oral Omega 3 Drusen: A phase II randomized, double-mask study to establish the safety and efficacy of High-Dose Oral Omega 3 in subjects with high-risk drusen secondary to dry age-related macular degeneration  26/03/2013

Foto49_3

 

Description

The objectives of this study are to evaluate the safety and efficacy of High-Dose Oral Omega 3 on the Photoreceptors/Retinal Pigment Epithelium/Bruch’s membrane complex in subjects with high-risk drusen secondary to age-related macular degeneration and to evaluate whether improvement in visual function occurs and progression to advanced stages of AMD is delayed.

Injeccions intravítriesDMAE seca o atròficaDMAE exsudativa o humidaRetinografiaAutofluorescènciaMicroperimetriaAngiografia amb fluoresceïnaTomografia de coherència òptica

Autor

Dr. Jordi Monés, M.D., Ph.D.
Número de Col·legiat COMB: 22.838
Director
Doctor en Medicina i Cirurgia
Especialista en Oftalmologia
Especialista en Retina, Màcula i Vitri

Última modificació: 29 Novembre, 2021 - 13:07